SPOTLIGHT -
Looking Forward: Advice for Clinicians and Discussing Unmet Needs in the R/R MM Landscape
Dr. Joshua Richter and Dr. Peter Forsberg close their discission with thoughtful advice for clinicians regarding the current and future treatment of patients with R/R MM.
Practical Considerations for Reducing Risk and Providing Supportive Care
Insights on supportive care measures to minimize or counter common adverse effects for patients with R/R MM taking selinexor-based therapies
Dosing Strategies and Adverse Events in Patients Treated with Selinexor
Discourse centered around dosing strategies for selinexor-based therapies.
Key Trial Data Supporting the Use of Selinexor in Patients with R/R MM
Two subject matter experts discuss keystone trials supporting the use of Selinexor in patients with R/R MM, each with unique dosing structures and different selinexor-based combinations.
An Overview of Treatment Options Available for Patients with R/R MM
Opening their discussion on relapsed/refractory multiple myeloma, Joshua Richter, MD and Peter Forsberg, MD review options for treatment sequencing, initiating treatment, and the mechanism of action for selinexor.
